Candel Therapeutics, Inc. CADL
8.77 USD +0.65 (+7.95%)
Nov 3, 2026, 3:16 PM EST
8.19 Day range 8.86
4.35 52-week range 14.00
- YTD
- +55.15%
- 1 year
- +67.93%
Analyst view
Price target (mean) 21.00 +139.6% upside
Now 8.77
- Target (low)
- 12.00
- Target (mean)
- 21.00
- Target (high)
- 29.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy0
- Buy8
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31 | -0.33 – -0.29 | -0.2262 | -37.0% | 0 | 0.0% | 2 |
| Next quarter | -0.325 | -0.33 – -0.32 | -0.291 | -11.7% | 0 | 0.0% | 2 |
| Current year | -1.00 | -1.28 – -0.74 | -0.8758 | -14.5% | 0 | 0.0% | 4 |
| Next year | -0.625 | -1.47 – 0.22 | -1.00 | +37.7% | 43.38M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Aug 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 13, 2026 | Stifel | Initiated | — | Buy |
| Apr 20, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 18, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 13, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 8, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Nov 21, 2025 | Freedom Broker | Maintained | Buy | Buy |
| Nov 14, 2025 | Citigroup | Maintained | Buy | Buy |
| Oct 28, 2025 | Stephens & Co. | Initiated | — | Overweight |
| Oct 21, 2025 | LifeSci Capital | Initiated | — | Outperform |
| Sep 29, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2025 | B of A Securities | Downgrade | Buy | Neutral |
| Apr 11, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 26, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 26, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 20, 2025 | Citigroup | Initiated | — | Buy |
| Feb 19, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Feb 7, 2025 | B of A Securities | Initiated | — | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 22, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2023 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 31, 2023 | Credit Suisse | Maintained | — | Outperform |
| Dec 7, 2022 | Credit Suisse | Maintained | — | Outperform |
| Dec 2, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 31, 2022 | BMO Capital | Maintained | — | Outperform |